Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Farmers Insurance
AstraZeneca
UBS
Chinese Patent Office

Generated: May 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,899,717

« Back to Dashboard

Summary for Patent: 6,899,717
Title: Methods and apparatus for delivery of ocular implants
Abstract:An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
Inventor(s): Weber; David (Danville, CA), Kane; Ingrid (Los Altos, CA), Rehal; Mike (Boulder Creek, CA), Lathrop, III; Robert L. (Santa Clara, CA), Aptekarev; Kenny (Santa Cruz, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:10/246,884
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,899,717
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Drugs Protected by US Patent 6,899,717

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Allergan OZURDEX dexamethasone IMPLANT;INTRAVITREAL 022315-001 Jun 17, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial DELIVERING AN OCULAR IMPLANT AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION OF THE APPROVED LABELING OF OZURDEX ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,899,717

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003272575 ➤ Try a Free Trial
Brazil 0314288 ➤ Try a Free Trial
Brazil PI0314288 ➤ Try a Free Trial
Canada 2495621 ➤ Try a Free Trial
Canada 2567140 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Express Scripts
QuintilesIMS
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.